Authors
Latest:
Casting Doubt: Are Compound Interventions Effective?How can we better engage patients for greater adherence rates?
Latest:
The Underappreciated Risks of Hospital IV CompoundingTechnology can help reduce error rates in IV compounding.
Latest:
PBMs Look to the FuturePBMs are evolving, but what will they be evolving into and will they be more transparent?
Latest:
Clinical Challenge: Treating Nasal Congestion with Concomitant HypertensionIn Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.
Latest:
Clinical Challenge: Treating Nasal Congestion with Concomitant HypertensionIn Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.
Latest:
Edaravone (Radicava) for ALSEdaravone has been approved for patients with amyotropic lateral sclerosis.
Latest:
AST: The Linchpin of Antimicrobial StewardshipAntimicrobial susceptibility testing (AST) for newer antibiotics is falling behind because there is a lag time between FDA approval and inclusion in commercial AST devices.
Latest:
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
Latest:
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaA new era of treatment has arrived-here’s what you need to know.
Latest:
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
Latest:
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
Latest:
Health System Pharmacies Adopt Next-Generation TechIt's time for pharmacies to move into the future: Industry 4.0.
Latest:
Take a Cue from Your Queues!Queueing theory can help pharmacy managers control lines, wait times, and staffing issues.
Latest:
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
Latest:
What Pharmacists Need to Know About EpidiolexThe FDA recently approved cannabidiol oral solution to treat seizures.
Latest:
The Value of Board-Certified Psychiatric PharmacistsBeing recognized as a BCPP brings professional recognition and credibility as an expert in psychopharmacology and behavioral health matters.
Latest:
Pediatric Asthma: An Update for PharmacistsIn this month's peer-reviewed article, learn more about the illness affecting millions.
Latest:
Pediatric Asthma: An Update for PharmacistsIn this month's peer-reviewed article, learn more about the illness affecting millions.
Latest:
Pediatric Asthma: An Update for PharmacistsIn this month's peer-reviewed article, learn more about the illness affecting millions.
Latest:
The Regimen: Portrayal of Pharmacists in MediaJeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.
Latest:
Pharmacy Education: Foundation for Providing HealthAACP offers a rebuttal to a Drug Topics opinion article.
Latest:
3 compliance rules pharmacies must knowWith 2016 well underway, pharmacies of all sizes should review recent regulatory updates to ensure compliance with rules already in effect, and preparation for those to be implemented soon. Three, in particular, warrant a close look.
Latest:
Natural Disasters Pose Risk to Heart HealthThe primary challenges include disruption in medication supply and increased demand for essential medications due to heightened health concerns.
Latest:
FDA approves rolapitant to prevent chemotherapy-induced nausea and vomitingRolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.
Latest:
Why You Should Become Board Certified in OncologyNew developments in cancer treatment require medication experts-here's how you can become that expert.
Latest:
NASH Drug Pipeline Shows PromiseAnalysts have forecasted the market for NASH drugs could reach $20 billion by 2025.
